Roche Laboratories, Inc. Sustainability Profile
Roche Laboratories, Inc., a prominent player in the global healthcare sector, is headquartered in the United States. Founded in 1896, Roche has established itself as a leader in pharmaceuticals and diagnostics, with a strong presence in North America, Europe, and Asia. The company is renowned for its innovative solutions in oncology, immunology, and infectious diseases, offering a diverse portfolio of prescription medications and cutting-edge diagnostic tools. Roche's commitment to research and development has led to significant milestones, including breakthroughs in personalised medicine. With a robust market position, Roche consistently ranks among the top pharmaceutical companies worldwide, recognised for its contributions to improving patient outcomes. The unique integration of diagnostics and therapeutics sets Roche apart, making it a trusted name in the industry.
DitchCarbon Score
How does Roche Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Laboratories, Inc.'s score of 49 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Laboratories, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Roche Holding AG, which may influence its climate commitments and emissions reporting. As part of its corporate family, Roche Laboratories inherits climate initiatives and targets from Roche Holding AG. However, there are no documented reduction targets or specific climate pledges available for Roche Laboratories at this time. The absence of emissions data and reduction initiatives suggests that the company may still be in the process of establishing its own climate strategy or reporting framework. Roche Laboratories is part of a broader industry context where many companies are increasingly focusing on sustainability and carbon reduction. The lack of specific emissions data highlights the importance of transparency and accountability in corporate climate commitments. As the company develops its strategies, it may align with industry standards and best practices to address climate change effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 419,306,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 443,583,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 160,632,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Roche Laboratories, Inc.'s Industry?
How Carbon Intensive is Roche Laboratories, Inc.'s Location?
Roche Laboratories, Inc.'s Scope 3 Categories Breakdown
Roche Laboratories, Inc.'s Scope 3 emissions, which decreased by 8% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Roche Laboratories, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Roche Laboratories, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
